Page last updated: 2024-08-22

isopentenyladenosine and Benign Neoplasms

isopentenyladenosine has been researched along with Benign Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cicatiello, L; Ciuffreda, P; Colombo, F; De Cecco, L; Dragani, TA; Falvella, FS; Ottria, R; Pratesi, G; Santaniello, E; Tortoreto, M; Weisz, A	1
Baldoli, E; Casati, S; Ciuffreda, P; Lopez, E; Maier, JA; Ottria, R	1
Colombo, F; Dragani, TA; Falvella, FS; Spinola, M	1
Bifulco, M; Caruso, MG; Laezza, C; Malfitano, AM; Proto, MC; Santoro, A	1
Keith, DE; Slavik, M; Vold, BS	1

Reviews

1 review(s) available for isopentenyladenosine and Benign Neoplasms

Article	Year
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug. Anti-cancer agents in medicinal chemistry, 2008, Volume: 8, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Humans; Isopentenyladenosine; Molecular Structure; Neoplasms	2008

Other Studies

4 other study(ies) available for isopentenyladenosine and Benign Neoplasms

Article	Year
Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine. International journal of cancer, 2009, May-01, Volume: 124, Issue:9 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Isopentenyladenosine; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; RNA, Messenger; Tumor Stem Cell Assay	2009
Effects of cytokinins, cytokinin ribosides and their analogs on the viability of normal and neoplastic human cells. Anticancer research, 2011, Volume: 31, Issue:10 Topics: Adenosine; Cell Line, Tumor; Cell Survival; Cisplatin; Cytokinins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Isopentenyladenosine; Neoplasms; Neutral Red; Ribonucleosides; Tumor Stem Cell Assay; Zeatin	2011
N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers. International journal of cancer, 2007, Jun-15, Volume: 120, Issue:12 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Cell Shape; DNA, Neoplasm; Dose-Response Relationship, Drug; Epithelial Cells; Geranyltranstransferase; HT29 Cells; Humans; Isopentenyladenosine; Neoplasms; Time Factors; Tumor Stem Cell Assay	2007
Urine levels of N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2'-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. Cancer research, 1982, Volume: 42, Issue:12 Topics: Adenosine; Chromatography, High Pressure Liquid; Guanosine; Humans; Isopentenyladenosine; Neoplasms; Radioimmunoassay; Reference Values	1982